Live Breaking News & Updates on Michael Loschi

Stay updated with breaking news from Michael loschi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference

LYON, France, March 12, 2024 Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, will present extended results from its Early Access Program for patients with aGvHD that were treated with MaaT013 and, for the first time, Overall Survival data after 12 months in more patients. The data will be shared during an oral p ....

United States , Glasgow City , United Kingdom , Alexander Schauwvlieghe , Michael Loschi , Early Access Program , Corporate Communications , American Society Of Hematology , Meeting Of The European Society For Blood , Trophic Communications , Senior Pr Corporate Communications , Graft Vs Host Disease , Maat Pharma , Regulatory News , Microbiome Ecosystem , Overall Survival , Annual Meeting , European Society , Marrow Transplantation , Overall Response Rate , Nice Hospital , Oral Presentation , Microbiome Ecosystem Therapies , Euronext Paris , Investor Relations , Media Relations ,